NIOX Group Plc
OTC: CSSPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jonathan Emms
- Employees
- 97
- Headquarters
- Oxford, United Kingdom
- IPO year
- 2020
- Market cap
- $336.5M
- Website
- https://www.niox.com
Loading CSSPF…
Loading profile data…Frequently asked questions about CSSPF
What does NIOX Group Plc (CSSPF) do?
Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2...
Where does CSSPF trade?
NIOX Group Plc (CSSPF) trades on the Other OTC.
What sector is CSSPF in?
NIOX Group Plc (CSSPF) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of NIOX Group Plc?
Jonathan Emms is the chief executive officer of NIOX Group Plc (CSSPF).
Where is NIOX Group Plc headquartered?
NIOX Group Plc is headquartered in United Kingdom.
Does CSSPF pay a dividend?
Yes — NIOX Group Plc (CSSPF) paid a trailing twelve-month dividend of USD 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CSSPF go public?
NIOX Group Plc (CSSPF) completed its initial public offering in 2020.